title: [Trastuzumab emtansine in the systemic treatment of HER-2-positive breast cancer brain metastases].
authors.affiliation: Institut de cancérologie de l'Ouest, département d'oncologie médicale, 44800 Saint-Herblain, France.
authors.forename: Jean-Sébastien
authors.initials: JS
authors.lastname: Frenel
authors.affiliation: Centre Léon-Bérard, département d'oncologie médicale, 69008 Lyon, France.
authors.forename: Olivia
authors.initials: O
authors.lastname: Bally
authors.affiliation: Institut de cancérologie de l'Ouest, département d'oncologie médicale, 44800 Saint-Herblain, France.
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Bourbouloux
authors.affiliation: Institut de cancérologie de l'Ouest, département d'oncologie médicale, 44800 Saint-Herblain, France.
authors.forename: Dominique
authors.initials: D
authors.lastname: Berton-Rigaud
authors.affiliation: Institut de cancérologie de l'Ouest, département d'oncologie médicale, 44800 Saint-Herblain, France.
authors.forename: Mario
authors.initials: M
authors.lastname: Campone
authors.affiliation: Centre Léon-Bérard, département d'oncologie médicale, 69008 Lyon, France.
authors.forename: Thomas
authors.initials: T
authors.lastname: Bachelot
authors.affiliation: Centre Léon-Bérard, département d'oncologie médicale, 69008 Lyon, France. Electronic address: pierre-etienne.heudel@lyon.unicancer.fr.
authors.forename: Pierre-Étienne
authors.initials: PÉ
authors.lastname: Heudel
mesh_terms: D000080044:Ado-Trastuzumab Emtansine; D000328:Adult; D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary*; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008453:Maytansine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D000068878:Trastuzumab
chemical_list: D000080044:Ado-Trastuzumab Emtansine; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D008453:Maytansine; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C508053:ERBB2 protein, human
keywords: Anti-HER2 systemic treatment; Brain metastases; Breast cancer; Cancer du sein; Métastases cérébrales; Traitement systémique anti-HER2